ABVIRIS DEUTSCHLAND GMBH has a total of 15 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets biotechnology and measurement are NOVOCELLUS LTD, SHANGHAI RONGSHENG BIOTECH CO LTD and YANG LINGYAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Germany | 1 | |
#7 | Hungary | 1 | |
#8 | Republic of Korea | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hilfrich Ralf | 13 |
#2 | Ralf Hilfrich | 2 |
Publication | Filing date | Title |
---|---|---|
DE102016124171A1 | Serological test for therapy control of HPV16 positive carcinomas | |
EP2758785A1 | Method for checking the self-healing process carried out by the immune system of a test subject infected with human papillomavirus | |
EP3413048A1 | Quick test for the qualitative and/or quantitative analysis of human papillomavirus antibodies in bodily fluid and device for carrying out the quick test |